Literature DB >> 25693861

Aetiological stratification as a conceptual framework for gene-by-environment interaction research in psychiatry.

Ruud van Winkel1.   

Abstract

It has been argued that gene-by-environment interactions (G × E) research is unlikely to progress knowledge about psychiatric disorders, in contrast to genome-wide association (GWA) studies. However, G × E approaches are not alternatives for gene-hunting but a way to identify genetic and biological mechanisms within subgroups of patients exposed to a similar aetiological (environmental) factor via a process of 'aetiological stratification'. This is important as diagnostic categories targeted by GWA studies are inherently heterogeneous and lack biological validity. Aetiological stratification builds on examining possible phenotypic and/or molecular specificity associated with exposure to the environmental factor across multiple potentially relevant disorders, combined with efforts to identify an underlying biological substrate. G × E hypotheses within this framework investigate (1) which genes influence the degree to which individuals develop identified biological alterations that link environmental exposure to specific phenotypic and/or molecular characteristics within or across psychiatric disorders and (2) which genes are implicated in determining the development of psychopathology once this biological alteration has been brought about. As gene-hunting is not a goal in itself, the examination of pathway and/or polygenic risk scores may be more informative than the examination of individual markers, at the same time reducing multiple testing and the associated risk of spurious findings.

Entities:  

Keywords:  schizoaffective disorder

Year:  2015        PMID: 25693861      PMCID: PMC6998137          DOI: 10.1017/S2045796014000559

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  19 in total

1.  Misconceptions about gene-environment interactions in psychiatry.

Authors:  Stanley Zammit; Michael J Owen; Glyn Lewis
Journal:  Evid Based Ment Health       Date:  2010-08

Review 2.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

Review 3.  Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis.

Authors:  Ruud van Winkel; Rebecca Kuepper
Journal:  Annu Rev Clin Psychol       Date:  2014-01-20       Impact factor: 18.561

Review 4.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry.

Authors:  Laramie E Duncan; Matthew C Keller
Journal:  Am J Psychiatry       Date:  2011-09-02       Impact factor: 18.112

5.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.

Authors: 
Journal:  Lancet       Date:  2013-02-28       Impact factor: 79.321

Review 6.  Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders.

Authors:  Jonathan Sebat; Deborah L Levy; Shane E McCarthy
Journal:  Trends Genet       Date:  2009-10-31       Impact factor: 11.639

Review 7.  Schizophrenia genetics: the search for a hard lead.

Authors:  Patrick F Sullivan
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

Review 8.  Molecular genetic gene-environment studies using candidate genes in schizophrenia: a systematic review.

Authors:  Gemma Modinos; Conrad Iyegbe; Diana Prata; Margarita Rivera; Matthew J Kempton; Lucia R Valmaggia; Pak C Sham; Jim van Os; Philip McGuire
Journal:  Schizophr Res       Date:  2013-10-02       Impact factor: 4.939

Review 9.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Authors:  Shuji Ogino; Paul Lochhead; Andrew T Chan; Reiko Nishihara; Eunyoung Cho; Brian M Wolpin; Jeffrey A Meyerhardt; Alexander Meissner; Eva S Schernhammer; Charles S Fuchs; Edward Giovannucci
Journal:  Mod Pathol       Date:  2013-01-11       Impact factor: 7.842

10.  Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions.

Authors:  Torsten Klengel; Divya Mehta; Christoph Anacker; Monika Rex-Haffner; Jens C Pruessner; Carmine M Pariante; Thaddeus W W Pace; Kristina B Mercer; Helen S Mayberg; Bekh Bradley; Charles B Nemeroff; Florian Holsboer; Christine M Heim; Kerry J Ressler; Theo Rein; Elisabeth B Binder
Journal:  Nat Neurosci       Date:  2012-12-02       Impact factor: 24.884

View more
  4 in total

1.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Authors:  Shuji Ogino; Reiko Nishihara; Tyler J VanderWeele; Molin Wang; Akihiro Nishi; Paul Lochhead; Zhi Rong Qian; Xuehong Zhang; Kana Wu; Hongmei Nan; Kazuki Yoshida; Danny A Milner; Andrew T Chan; Alison E Field; Carlos A Camargo; Michelle A Williams; Edward L Giovannucci
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

Review 2.  Integration of molecular pathology, epidemiology and social science for global precision medicine.

Authors:  Akihiro Nishi; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Andy S Tan; Ichiro Kawachi; Shuji Ogino
Journal:  Expert Rev Mol Diagn       Date:  2015-12-04       Impact factor: 5.225

3.  Molecular pathological epidemiology gives clues to paradoxical findings.

Authors:  Reiko Nishihara; Tyler J VanderWeele; Kenji Shibuya; Murray A Mittleman; Molin Wang; Alison E Field; Edward Giovannucci; Paul Lochhead; Shuji Ogino
Journal:  Eur J Epidemiol       Date:  2015-10-07       Impact factor: 8.082

4.  A Rosetta stone for epidemiology: genomic risk profile scores contain clues related to modifiable risk factors.

Authors:  John J McGrath
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-23       Impact factor: 6.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.